" /> Anagrelide Prolonged-release Formulation - CISMeF





Preferred Label : Anagrelide Prolonged-release Formulation;

NCIt synonyms : Anagrelide Retard;

NCIt definition : A prolonged-release tablet formulation containing the quinazoline anagrelide, with antiplatelet activity. Although the exact mechanism of action through which anagrelide exerts its effect has yet to be fully elucidated, this agent inhibits the maturation of megakaryocytes into platelets, which reduces platelet production. Anagrelide also inhibits cyclic AMP phosphodiesterase III (PDEIII), which prevents PDEIII-mediated platelet aggregation. This may prevent essential thrombocythemia and thrombosis.;

NCI Metathesaurus CUI : CL472323;

Details


You can consult :


Nous contacter.
25/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.